APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valpromide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valpromide Industry Growth and Trends Forecast to 2032

2 January 202693 pages

Choose your research edition.

Industry ResearchValpromide Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Valpromide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Valpromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valpromide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Valpromide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Valpromide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valpromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valpromide include Novartis Pharmaceuticals, Beijing Sail Biopharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Hunan Hansen Pharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., China Resources Double-Crane Pharmaceutical Co., Ltd. and Shanxi Luliang Traditional Chinese Medicine Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valpromide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valpromide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valpromide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valpromide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valpromide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valpromide Market by Company

Novartis Pharmaceuticals

Beijing Sail Biopharmaceutical Co., Ltd.

Hunan Dino Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

China Resources Double-Crane Pharmaceutical Co., Ltd.

Shanxi Luliang Traditional Chinese Medicine Factory

Valpromide Segment by Type

Pill

Suppository

Capsule

Valpromide Segment by Application

Hospital

Pharmacy

Others

Valpromide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valpromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valpromide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valpromide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valpromide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valpromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pill Table 2. Major Company of Suppository Table 3. Major Company of Capsule Table 4. Global Valpromide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Valpromide Sales by Type (2021-2026) & (K Units) Table 6. Global Valpromide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Valpromide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Valpromide Sales Market Share in Value by Type (2021-2026) Table 9. Global Valpromide Price by Type (2021-2026) & (US$/Unit) Table 10. Global Valpromide Sales by Type (2027-2032) & (K Units) Table 11. Global Valpromide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Valpromide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Valpromide Sales Market Share in Value by Type (2027-2032) Table 14. Global Valpromide Price by Type (2027-2032) & (US$/Unit) Table 15. North America Valpromide Sales by Type (2021-2026) & (K Units) Table 16. North America Valpromide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Valpromide Sales by Type (2021-2026) & (K Units) Table 18. Europe Valpromide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Valpromide Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Valpromide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Valpromide Sales by Type (2021-2026) & (K Units) Table 22. Latin America Valpromide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Valpromide Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Valpromide Sales by Type (2021-2026) & (US$ Million) Table 25. Valpromide Industry Trends Table 26. Valpromide Industry Drivers Table 27. Valpromide Industry Opportunities and Challenges Table 28. Valpromide Industry Restraints Table 29. Global Valpromide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Valpromide Revenue Market Share by Company (2021-2026) Table 31. Global Valpromide Sales by Company (2021-2026) & (K Units) Table 32. Global Valpromide Sales Share by Company (2021-2026) Table 33. Global Valpromide Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Valpromide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Valpromide Major Company Production Sites and Headquarters Table 36. Global Valpromide Company, Product Type & Application Table 37. Global Valpromide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Valpromide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Valpromide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Valpromide Sales by Region (2021-2026) & (K Units) Table 42. Global Valpromide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Valpromide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Valpromide Sales Market Share in Value by Region (2021-2026) Table 45. Global Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Valpromide Sales by Region (2027-2032) & (K Units) Table 47. Global Valpromide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Valpromide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Valpromide Sales Market Share in Value by Region (2027-2032) Table 50. Global Valpromide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Valpromide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Valpromide Sales by Application (2021-2026) & (K Units) Table 53. Global Valpromide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Valpromide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Valpromide Sales Market Share in Value by Application (2021-2026) Table 56. Global Valpromide Price by Application (2021-2026) & (US$/Unit) Table 57. Global Valpromide Sales by Application (2027-2032) & (K Units) Table 58. Global Valpromide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Valpromide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Valpromide Sales Market Share in Value by Application (2027-2032) Table 61. Global Valpromide Price by Application (2027-2032) & (US$/Unit) Table 62. North America Valpromide Sales by Application (2021-2026) & (K Units) Table 63. North America Valpromide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Valpromide Sales by Application (2021-2026) & (K Units) Table 65. Europe Valpromide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Valpromide Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Valpromide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Valpromide Sales by Application (2021-2026) & (K Units) Table 69. Latin America Valpromide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Valpromide Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Valpromide Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Pharmaceuticals Company Information Table 73. Novartis Pharmaceuticals Business Overview Table 74. Novartis Pharmaceuticals Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Pharmaceuticals Valpromide Product Portfolio Table 76. Novartis Pharmaceuticals Recent Development Table 77. Beijing Sail Biopharmaceutical Co., Ltd. Company Information Table 78. Beijing Sail Biopharmaceutical Co., Ltd. Business Overview Table 79. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio Table 81. Beijing Sail Biopharmaceutical Co., Ltd. Recent Development Table 82. Hunan Dino Pharmaceutical Co., Ltd. Company Information Table 83. Hunan Dino Pharmaceutical Co., Ltd. Business Overview Table 84. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 86. Hunan Dino Pharmaceutical Co., Ltd. Recent Development Table 87. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 88. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 89. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 91. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 92. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 93. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 94. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 96. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 97. China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information Table 98. China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview Table 99. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 101. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Development Table 102. Shanxi Luliang Traditional Chinese Medicine Factory Company Information Table 103. Shanxi Luliang Traditional Chinese Medicine Factory Business Overview Table 104. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio Table 106. Shanxi Luliang Traditional Chinese Medicine Factory Recent Development Table 107. North America Valpromide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Valpromide Sales by Country (2021-2026) & (K Units) Table 109. North America Valpromide Sales Market Share by Country (2021-2026) Table 110. North America Valpromide Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Valpromide Sales Market Share Forecast by Country (2027-2032) Table 112. North America Valpromide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Valpromide Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Valpromide Market Share by Country (2021-2026) Table 115. North America Valpromide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Valpromide Market Share Forecast by Country (2027-2032) Table 117. Europe Valpromide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Valpromide Sales by Country (2021-2026) & (K Units) Table 119. Europe Valpromide Sales Market Share by Country (2021-2026) Table 120. Europe Valpromide Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Valpromide Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Valpromide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Valpromide Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Valpromide Market Share by Country (2021-2026) Table 125. Europe Valpromide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Valpromide Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Valpromide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Valpromide Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Valpromide Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Valpromide Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Valpromide Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Valpromide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Valpromide Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Valpromide Market Share by Country (2021-2026) Table 135. Asia-Pacific Valpromide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Valpromide Market Share Forecast by Country (2027-2032) Table 137. Latin America Valpromide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Valpromide Sales by Country (2021-2026) & (K Units) Table 139. Latin America Valpromide Sales Market Share by Country (2021-2026) Table 140. Latin America Valpromide Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Valpromide Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Valpromide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Valpromide Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Valpromide Market Share by Country (2021-2026) Table 145. Latin America Valpromide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Valpromide Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Valpromide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Valpromide Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Valpromide Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Valpromide Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Valpromide Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Valpromide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Valpromide Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Valpromide Market Share by Country (2021-2026) Table 155. Middle East and Africa Valpromide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Valpromide Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Valpromide Distributors List Table 160. Valpromide Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Valpromide Image Figure 2. Global Valpromide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valpromide Market Size (2021-2032) & (US$ Million) Figure 4. Global Valpromide Sales (2021-2032) & (K Units) Figure 5. Pill Image Figure 6. Global Pill Sales YoY Growth (2021-2032) & (K Units) Figure 7. Suppository Image Figure 8. Global Suppository Sales YoY Growth (2021-2032) & (K Units) Figure 9. Capsule Image Figure 10. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Valpromide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Valpromide Market Share by Type 2025 VS 2032 Figure 13. North America Valpromide Sales Market Share in Volume by Type in 2025 Figure 14. North America Valpromide Sales Market Share in Value by Type in 2025 Figure 15. Europe Valpromide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Valpromide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Valpromide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Valpromide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Valpromide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Valpromide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Valpromide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Valpromide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Valpromide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Valpromide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Valpromide Market Share by Application 2025 VS 2032 Figure 33. North America Valpromide Sales Market Share in Volume by Application in 2025 Figure 34. North America Valpromide Sales Market Share in Value by Application in 2025 Figure 35. Europe Valpromide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Valpromide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Valpromide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Valpromide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Valpromide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Valpromide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Valpromide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Valpromide Sales Market Share in Value by Application in 2025 Figure 43. North America Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Valpromide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Valpromide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Valpromide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Valpromide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valpromide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Valpromide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Valpromide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valpromide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Valpromide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Valpromide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valpromide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Valpromide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Valpromide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Valpromide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valpromide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Valpromide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Valpromide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Valpromide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Suppository
  • Capsule
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Novartis Pharmaceuticals
  • Beijing Sail Biopharmaceutical Co., Ltd.
  • Hunan Dino Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Shanxi Luliang Traditional Chinese Medicine Factory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valpromide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valpromide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valpromide Market by Type
  6. 1.3.1 Pill
  7. 1.3.2 Suppository
  8. 1.3.3 Capsule
  9. 1.4 Global Valpromide Market Size by Type
  10. 1.4.1 Global Valpromide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Valpromide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Valpromide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Valpromide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Valpromide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Valpromide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Valpromide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Valpromide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valpromide Industry Trends
  2. 2.2 Valpromide Industry Drivers
  3. 2.3 Valpromide Industry Opportunities and Challenges
  4. 2.4 Valpromide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valpromide Revenue (2021-2026)
  2. 3.2 Global Top Players by Valpromide Sales (2021-2026)
  3. 3.3 Global Top Players by Valpromide Price (2021-2026)
  4. 3.4 Global Valpromide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valpromide Major Company Production Sites & Headquarters
  6. 3.6 Global Valpromide Company, Product Type & Application
  7. 3.7 Global Valpromide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valpromide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valpromide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valpromide Tier 1, Tier 2, and Tier 3
4 Valpromide Regional Status and Outlook
  1. 4.1 Global Valpromide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valpromide Historic Market Size by Region
  3. 4.2.1 Global Valpromide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valpromide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valpromide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valpromide Forecasted Market Size by Region
  7. 4.3.1 Global Valpromide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valpromide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valpromide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valpromide by Application
  1. 5.1 Valpromide Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Valpromide Market Size by Application
  6. 5.2.1 Global Valpromide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Valpromide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Valpromide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Valpromide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Valpromide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Valpromide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Valpromide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Valpromide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis Pharmaceuticals
  2. 6.1.1 Novartis Pharmaceuticals Company Information
  3. 6.1.2 Novartis Pharmaceuticals Business Overview
  4. 6.1.3 Novartis Pharmaceuticals Valpromide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Pharmaceuticals Valpromide Product Portfolio
  6. 6.1.5 Novartis Pharmaceuticals Recent Developments
  7. 6.2 Beijing Sail Biopharmaceutical Co., Ltd.
  8. 6.2.1 Beijing Sail Biopharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Beijing Sail Biopharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio
  12. 6.2.5 Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Hunan Dino Pharmaceutical Co., Ltd.
  14. 6.3.1 Hunan Dino Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Hunan Dino Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  18. 6.3.5 Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Hunan Hansen Pharmaceutical Co., Ltd.
  20. 6.4.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  24. 6.4.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  26. 6.5.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  30. 6.5.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 China Resources Double-Crane Pharmaceutical Co., Ltd.
  32. 6.6.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  36. 6.6.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shanxi Luliang Traditional Chinese Medicine Factory
  38. 6.7.1 Shanxi Luliang Traditional Chinese Medicine Factory Company Information
  39. 6.7.2 Shanxi Luliang Traditional Chinese Medicine Factory Business Overview
  40. 6.7.3 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio
  42. 6.7.5 Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
7 North America by Country
  1. 7.1 North America Valpromide Sales by Country
  2. 7.1.1 North America Valpromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valpromide Sales by Country (2021-2026)
  4. 7.1.3 North America Valpromide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valpromide Market Size by Country
  6. 7.2.1 North America Valpromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valpromide Market Size by Country (2021-2026)
  8. 7.2.3 North America Valpromide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valpromide Sales by Country
  2. 8.1.1 Europe Valpromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valpromide Sales by Country (2021-2026)
  4. 8.1.3 Europe Valpromide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valpromide Market Size by Country
  6. 8.2.1 Europe Valpromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valpromide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valpromide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valpromide Sales by Country
  2. 9.1.1 Asia-Pacific Valpromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valpromide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valpromide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valpromide Market Size by Country
  6. 9.2.1 Asia-Pacific Valpromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valpromide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valpromide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valpromide Sales by Country
  2. 10.1.1 South America Valpromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valpromide Sales by Country (2021-2026)
  4. 10.1.3 South America Valpromide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valpromide Market Size by Country
  6. 10.2.1 South America Valpromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valpromide Market Size by Country (2021-2026)
  8. 10.2.3 South America Valpromide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valpromide Sales by Country
  2. 11.1.1 Middle East and Africa Valpromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valpromide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valpromide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valpromide Market Size by Country
  6. 11.2.1 Middle East and Africa Valpromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valpromide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valpromide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valpromide Value Chain Analysis
  2. 12.1.1 Valpromide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valpromide Production Mode & Process
  7. 12.2 Valpromide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valpromide Distributors
  10. 12.2.3 Valpromide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst